InvestorsHub Logo
icon url

eb0783

10/24/16 10:24 PM

#277144 RE: biopharm #277131

Biopharm, nice article on Thiel and why he invested in that biotech. I especially liked this note which sounds a lot like what we have in PPHM:

if you are trying to build an end-to-end next-generation pharma company, then actually doing a lot of these things internally is correct. The ability to do complex coordination of different pieces of a business and make them work together is a very underrated entrepreneurial skill.


Owning Avid takes a lot of the complexity out of the different peices needed to get approval of and to market a new drug. Kinda makes you think that these guys, that so many have been saying do not know what they are doing, really DO KNOW what they are doing. Maybe Peter Thiel will see the same benefits in a PPHM investment that he did in Stemcentrx.
icon url

biopharm

09/20/17 12:38 PM

#312320 RE: biopharm #277131

..I wonder what Peter Thiel has up his sleeve for Peregrine Pharmaceuticals

https://www.technologyreview.com/s/541226/peter-thiel-explains-biotech-investing-rationale-get-rid-of-randomness/



Now if Steve King CEO of Peregrine could only get Peter Thiel to sit down for the afternoon

Notice how Mr Thiel says mostly all life science funds have all gone out of business in the past 15 years ....points at regulatory rules(think clinical trial Sunrise) and makes notes of $1.3 Billion to make it thru the FDA system (roadblocks lol)

So one afternoon Mr Thiel could see how Peregrine has spent MUCH less than $1.3 Billion ....but maybe that number is there since most companies give up and sell out before they have time to make it and one needs a strong enough IP patent portfolio to even make it with a bit of luck ....

Wonder if Andreas Thiel seeing some PS Targeting

https://www.google.com/url?sa=t&source=web&rct=j&url=%23&ved=0ahUKEwjNpfC6lLTWAhWs64MKHTC9AjoQwqsBCCcwAA&usg=AFQjCNF1sHlk2z9QIx28jtvfnGP_UlkifA